Urine-based detection of HPV for cervical cancer screening: Time for standardized tests
- PMID: 37185853
- DOI: 10.1002/jmv.28737
Urine-based detection of HPV for cervical cancer screening: Time for standardized tests
Abstract
Cervical cancer is preventable because it has an established etiology, mainly attributed to a detectable pathogen, human papillomavirus (HPV). In 2018, the world health organization issued an unprecedented call for global action to eliminate cervical cancer by 2030. The adaptation of regular screening programs is fundamental to achieve the goal of cervical cancer elimination. However, it is still difficult to achieve satisfactory coverage rates of screening in developing countries as well as in developed countries because many women are reluctant to participate in gynecologic examination. HPV detection in urine is a convenient, widely acceptable by women and relatively affordable without the necessity for clinical visits to improve the coverage rates of cervical cancer screening. Unfortunately, the clinical implementation of urine-based tests for HPV detection has been hindered by the lack of standardized tests. Further optimization of protocols and standardization of urinary HPV detection are expected to be realized. With the advantages of urine sampling to overcome cost, personal, and cultural barriers, time has come for the standardized tests to facilitate a wide clinical implementation of urinary HPV detection that will significantly contribute to the WHO's goal, that is, to eliminate the cervical cancer globally.
Keywords: HPV; cervical cancer screening; detection; urine.
© 2023 Wiley Periodicals LLC.
References
REFERENCES
-
- Johnson CA, James D, Marzan A, Armaos M. Cervical cancer: an overview of pathophysiology and management. Semin Oncol Nurs. 2019;35(2):166-174. doi:10.1016/j.soncn.2019.02.003
-
- Gultekin M, Ramirez PT, Broutet N, Hutubessy R. World health organization call for action to eliminate cervical cancer globally. Int J Gynecologic Cancer. 2020;30(4):426-427. doi:10.1136/ijgc-2020-001285
-
- Lefeuvre C, De Pauw H, Le Duc Banaszuk AS, et al. Study protocol: randomised controlled trial assessing the efficacy of strategies involving self-sampling in cervical cancer screening. Int J Public Health. 2022;67:1604284. doi:10.3389/ijph.2022.1604284
-
- Bruni L, Serrano B, Roura E, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet. Global Health. 2022;10(8):e1115-e1127. doi:10.1016/S2214-109X(22)00241-8
-
- Lamsisi M, Li G, Chauleur C, Ennaji MM, Bourlet T. The potential of urine for human papillomavirus-related cervical cancer prevention. Future Virol. 2022;17(7):495-508. doi:10.2217/fvl-2021-0246
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous